Company / Operating Income per Share
Vaxcyte, Inc. Operating Income per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$6.79
FY2025
5-year range
-$6.79 / -$2.00
FY2021-FY2025
Trend
-45.4%
vs FY2024
Sector context
#183 of 201
Health Care
What the data says
Among 201 Health Care companies, Vaxcyte, Inc. is in the bottom 9% for operating income per share. Operating Income per Share has fluctuated over the past 8 years, ranging from $-14.27 in FY2019 to $-2.00 in FY2021.
Based on SEC 10-K filings.
-6.79 in FY2025.
Declined from $-4.82 to $-6.79 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 9% in Health CareTop 91% of 201This company -$6.79 Sector average -$28.56
▼
+76.2% above sector average
Key checks
Key Insights
- In FY2025, operating income per share decreased 45.4% year-over-year.
- Ranks #183 out of 201 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2021.
- Lowest operating income per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 2.94 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$6.79 | -45.4% |
| FY2024 | -$4.67 | +3.1% |
| FY2023 | -$4.82 | -34.6% |
| FY2022 | -$3.58 | -79.3% |
| FY2021 | -$2.00 | +34.1% |
| FY2020 | -$3.03 | +78.8% |
| FY2019 | -$14.27 | -45.8% |
| FY2018 | -$9.79 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026